Mather A. Carscallen
Vorstandsvorsitzender bei SabrTech, Inc.
Profil
Mather A.
Carscallen is the founder of SabrTech, Inc. (founded in 2010) and Algae-C, Inc. (founded in 2015) where he holds the titles of President & Chief Executive Officer and CEO, Director, Head-Pharmaceutical & APIs respectively.
He also worked as an Algal Cultivation Technician at the National Research Council of Canada.
Aktive Positionen von Mather A. Carscallen
Unternehmen | Position | Beginn |
---|---|---|
SabrTech, Inc.
SabrTech, Inc. Chemicals: SpecialtyProcess Industries SabrTech, Inc. provides methods for growing and harvesting algae to supply biofuel for the aviation industry. It develops a bioreactor to produce algae-based bioproducts such as fuel, food additives and composites. The company was founded by Mather A. Carscallen in August 2010 and is headquartered in Herring Cove, Canada. | Vorstandsvorsitzender | 01.08.2010 |
Algae-C, Inc.
Algae-C, Inc. BiotechnologyHealth Technology Algae-C, Inc. is a Canadian biotech company that specializes in developing and producing high-value active pharmaceutical ingredients using microalgae. Algae-C's high-value molecules are economical and environmentally sustainable, with applications in the pharmaceutical, nutraceutical, and therapeutic industries. The company's technology addresses multiple manufacturing challenges, including increased drug ingredient costs, supply chain risk, and high environmental impacts. Algae-C's platform is naturally carbon negative and intrinsically reduces risk and cost. The company creates designer algae that produce valuable plant-based ingredients for various industries. The company was founded in 2014 and is the largest algae biosynthetic research company in Canada, with over 34 dedicated researchers, including 16 PhDs. The company was founded in 2015 by Mather A. Carscallen, who has been the CEO since then. | Gründer | 01.01.2015 |
Ehemalige bekannte Positionen von Mather A. Carscallen
Unternehmen | Position | Ende |
---|---|---|
National Research Council of Canada
National Research Council of Canada Miscellaneous Commercial ServicesCommercial Services National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
SabrTech, Inc.
SabrTech, Inc. Chemicals: SpecialtyProcess Industries SabrTech, Inc. provides methods for growing and harvesting algae to supply biofuel for the aviation industry. It develops a bioreactor to produce algae-based bioproducts such as fuel, food additives and composites. The company was founded by Mather A. Carscallen in August 2010 and is headquartered in Herring Cove, Canada. | Process Industries |
National Research Council of Canada
National Research Council of Canada Miscellaneous Commercial ServicesCommercial Services National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON. | Commercial Services |
Algae-C, Inc.
Algae-C, Inc. BiotechnologyHealth Technology Algae-C, Inc. is a Canadian biotech company that specializes in developing and producing high-value active pharmaceutical ingredients using microalgae. Algae-C's high-value molecules are economical and environmentally sustainable, with applications in the pharmaceutical, nutraceutical, and therapeutic industries. The company's technology addresses multiple manufacturing challenges, including increased drug ingredient costs, supply chain risk, and high environmental impacts. Algae-C's platform is naturally carbon negative and intrinsically reduces risk and cost. The company creates designer algae that produce valuable plant-based ingredients for various industries. The company was founded in 2014 and is the largest algae biosynthetic research company in Canada, with over 34 dedicated researchers, including 16 PhDs. The company was founded in 2015 by Mather A. Carscallen, who has been the CEO since then. | Health Technology |